Mountain Valley MD Investor

CEO Updates

Mountain Valley MD Logo, Black, PNG
“Every single time I take a minute to read daily news, there are countless validations of the need for the ground-breaking work we are doing. The mountain of evidence of the power of Ivermectin to positively treatCOVID-19 as a therapeutic has been in the news hundreds of times over the past several weeks around the world.  The ongoing news of the billions of dollars in wasted costs spent simply to transport vaccines within expensive cold chain requirements.  The viral COVID-19 mutations that are requiring the culling of millions of animals on mass. And the sad fact that by the time you are done reading this, another child will have died from Malaria. We have so many very significant and transformation projects that are coming together in this first half of the year and all of them are driven towards solving massive global health and wellness problems.”
- Dennis Hancock, President & CEO of Mountain Valley MD
Mountain Valley MD Logo, Black, PNG
July 15, 2021
  //  CEO Update

MVMD Welcomes Two New Advisors to the Team

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
July 14, 2021
  //  CEO Update

MVMD Coverage in Forbes – “This Entrepreneur Is On A Mission To Tackle Global Health Challenges”

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
July 9, 2021
  //  CEO Update

MVMD News Coverage and Executive Interview

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
July 7, 2021
  //  CEO Update

MVMD Announces Results from FDA Cold Chain Evaluation

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
June 24, 2021
  //  CEO Update

MVMD Update: FDA, Oncology, Cold Chain, Husbandry and more

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
May 25, 2021
  //  CEO Update

MVMD to host live, virtual Q&A session with CEO on Wednesday, May 26 at 11am

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
May 19, 2021
  //  CEO Update

MVMD CEO Interview on The Dales Report

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
May 18, 2021
  //  CEO Update

MVMD Confirms Ivectosol™ Clears COVID-19 on all Three Variants Tested in BSL-4 Lab

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
May 11, 2021
  //  CEO Update

MVMD Update on Current Trials

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
May 4, 2021
  //  CEO Update

MVMD Interview discussing Cancer Patent and Trials

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
May 3, 2021
  //  CEO Update

MVMD Announces Pre-Clinical Cancer Trials and Related Cancer Patent Filing

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
April 20, 2021
  //  CEO Update

MVMD Proceeding with TSX Venture Exchange Application

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
March 30, 2021
  //  CEO Update

MVMD Progress; Addressing Short Attack

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
March 20, 2021
  //  CEO Update

MVMD – Q&A and Interview Drops

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
March 16, 2021
  //  CEO Update

MVMD Commencing Trials in Bangladesh, Striking Pharma Partnership Agreements

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
March 10, 2021
  //  CEO Update

MVMD Achieves Solubilization of Selemectin Drug, Files New Trademark

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
March 10, 2021
  //  CEO Update

MVMD Selactosol™ Invterview

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
March 4, 2021
  //  CEO Update

MVMD FDA 505(b)(2) Pathway Interviews

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
March 3, 2021
  //  CEO Update

MVMD Proceeding with FDA 505(b)(2) Pathway Application + Trial Updates

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
March 1, 2021
  //  CEO Update

MVMD Commencing Husbandry Animal Clinical Trials, Appoints Dr. of Veterinary Medicine to Advisory Board

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
March 1, 2021
  //  CEO Update

MVMD Clinical Trial Interview

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
February 25, 2021
  //  CEO Update

MVMD Completes Quicksome™ License Agreement with Mushroom Partner

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
February 22, 2021
  //  CEO Update

MVMD Testing South African COVID-19 Variant in Upcoming BSL-4 Clearance Trial

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
February 22, 2021
  //  CEO Update

MVMD – Mike Farber Interview on South African Variant News

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
February 21, 2021
  //  CEO Update

MVMD Interview with Jody Vance on Equity Guru

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
February 15, 2021
  //  CEO Update

MVMD News Coverage and CEO Interview on The Dales Report

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
February 11, 2021
  //  CEO Update

Mountain Valley MD story gaining global attention with interview coverage in South Africa’s BizNews

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
January 27, 2021
  //  CEO Update

MVMD Commencing on Covid-19 Trial

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
January 21, 2021
  //  CEO Update

“Can MVMD create a world without Polio… and then other viruses? They just might.”

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
January 20, 2021
  //  CEO Update

New MVMD Dose Sparing Patent Filed

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
January 19, 2021
  //  CEO Update

MVMD Interview with Jody Vance on Equity Guru

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
January 14, 2021
  //  CEO Update

Mike Farber Interview on Quicksome™ Patent

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
January 14, 2021
  //  CEO Update

MVMD Awarded Canadian Patent for Quicksome™ Technology

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
January 13, 2021
  //  CEO Update

MVMD – We Can’t Wait Any Longer!

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
January 11, 2021
  //  CEO Update

Media Release – MVMD Applies for OTCQB Market Listing in U.S.

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
January 8, 2021
  //  CEO Update

MVMD Update & Happy New Year!

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
December 24, 2020
  //  CEO Update

MVMD Files for Acceleration of Patent Examination

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
December 22, 2020
  //  CEO Update

New MVMD CEO Interview, Oversubscription of Private Placement

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
December 18, 2020
  //  CEO Update

MVMD Interview Update - Mike Farber, Director of Life Sciences

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
December 16, 2020
  //  CEO Update

MVMD CEO Interview on Proactive Investor this Morning

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
December 14, 2020
  //  CEO Update

MVMD Advisory Board Growth and Strategic Investment

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
December 10, 2020
  //  CEO Update

What a Crazy 24 Hours – New Media Release!

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
December 10, 2020
  //  CEO Update

MUST WATCH – ARE YOU WITH US? MVMD: Infinite Possibility

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
December 9, 2020
  //  CEO Update

MUST WATCH (video link) - Ivermectin Validation in COVID-19 Therapies!

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
December 5, 2020
  //  CEO Update

Exciting Times for You and Mountain Valley MD…

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
November 25, 2020
  //  CEO Update

MVMD Secures Quicksome™ License Agreement with Mushroom Partner and Strategic Sale of Subsidiary

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
November 11, 2020
  //  CEO Update

Mountain Valley MD confirms major breakthrough in solubilizing ivermectin, files patents to protect IP and related COVID-19 applications

View UpdateView Update
Mountain Valley MD Logo, Black, PNG
October 2, 2020
  //  CEO Update

Mountain Valley MD confirms successful Quicksome™ dosing in pre-clinical trial for the drug ivermectin

View UpdateView Update

Subscribe to Updates from MVMD

Stay plugged in on everything MVMD.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
*By Clicking "Sign Up" You agree to Mountain Valley MD's Privacy Policy